Solid Biosciences Inc.SLDBNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank50
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-2.83
↑ 53% vs avg
Percentile
P50
Within normal range
Streak
3 yr
Consecutive declineElevated
Average
-6.06
Historical baseline
PeriodValueYoY Change
2025-2.83-116.2%
2024-1.31-3.0%
2023-1.27-138.7%
2022-0.53+79.4%
2021-2.59+41.9%
2020-4.46-191.5%
2019-1.53+87.2%
2018-11.92+14.8%
2017-13.99+30.7%
2016-20.20-